Sierra Oncology Inc (SRRA)
US82640U4040 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -102.67M | -94.66M | -80.90M | -88.28M | -53.34M | |||
| Depreciation Amortization | 340.00K | 300.00K | 240.00K | 80.00K | 110.00K | |||
| Income Taxes - Deferred | 0.00 | -40.00K | 200.00K | N/A | -70.00K | |||
| Change In Working Capital | 1.29M | 2.54M | 800.00K | -1.98M | 1.38M | |||
| Interest Paid | N/A | N/A | 0.00 | 340.00K | 90.00K | |||
| Taxes Paid | 80.00K | 70.00K | 30.00K | -70.00K | 20.00K | |||
| Other non cash items | 13.29M | 12.89M | 27.30M | 38.98M | 6.80M | |||
| OPERATING CASH FLOW | -87.74M | -78.96M | -52.37M | -51.18M | -45.12M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -130.00K | -70.00K | -10.00K | -40.00K | -120.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -130.00K | -70.00K | -10.00K | -40.00K | -120.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -5.44M | 4.96M | |||
| Stock Issued/Repurchased | 249.45M | 79.81M | 8.90M | 98.18M | 46.18M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 254.29M | 79.81M | 8.90M | 92.74M | 51.13M | |||
| Exchange Rate Effect | N/A | -80.00K | 10.00K | -30.00K | -90.00K | |||
| CHANGE IN CASH | 166.36M | 700.00K | -43.47M | 41.49M | 5.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -87.74M | -78.96M | -52.37M | -51.18M | -45.12M | |||
| Capital Expenditure | -130.00K | -70.00K | -10.00K | -40.00K | -120.00K | |||
| FREE CASH FLOW | -87.87M | -79.03M | -52.38M | -51.22M | -45.24M | |||
All data in USD